Landry Ian, Chowdhury Tapati, Hussein Suemaya, Thomas Leno
Medicine, Icahn School of Medicine at Mt Sinai/NYC Health + Hospitals Queens, Jamaica, USA.
Internal Medicine, Icahn School of Medicine, Mount Sinai/NYC Health + Hospitals Queens, Jamaica, USA.
Cureus. 2021 Dec 7;13(12):e20228. doi: 10.7759/cureus.20228. eCollection 2021 Dec.
Hemolytic anemia with thrombocytopenia and organ damage raises suspicion for thrombotic microangiopathy (TMA), a pathology that results in thrombosis within the small vessels secondary to endothelial injury. While usually attributed to atypical hemolytic uremic syndrome (aHUS) or thrombotic thrombocytopenic purpura (TTP), an increasingly recognized and treatable entity is pseudo-thrombotic microangiopathic anemia (pseudo-TMA) secondary to severe vitamin B-12 deficiency. While TMA often requires expensive diagnostic testing and can lead to invasive treatment options such as plasma exchange, immunosuppression, and/or complement cascade blocking, pseudo-TMA requires only vitamin supplementation. Therefore, the prompt and accurate diagnosis of this entity is important for the clinician to recognize in order to avoid unnecessary health costs and institute appropriate treatment. We present the case of a 51-year-old male without any past medical history, who presented with generalized weakness, dyspnea on exertion, and decreased exercise tolerance for several months and was found to have severe microangiopathic anemia with work-up concerning for TTP. After stabilization, he was found to have severe B-12 deficiency secondary to newly diagnosed pernicious anemia and was treated with subcutaneous B-12 injections with improvement in clinical symptoms and laboratory parameters. This presentation highlights the need for prompt diagnosis and high clinical suspicion for vitamin deficiencies as a source of pseudo-microangiopathy.
伴有血小板减少和器官损害的溶血性贫血会引发对血栓性微血管病(TMA)的怀疑,TMA是一种因内皮损伤继发于小血管内血栓形成的病理状态。虽然通常归因于非典型溶血性尿毒症综合征(aHUS)或血栓性血小板减少性紫癜(TTP),但一种日益被认识且可治疗的实体是继发于严重维生素B12缺乏的假性血栓性微血管病性贫血(假性TMA)。虽然TMA通常需要昂贵的诊断检测,并可能导致诸如血浆置换、免疫抑制和/或补体级联阻断等侵入性治疗选择,但假性TMA仅需要补充维生素。因此,临床医生及时准确地诊断该实体很重要,以便避免不必要的医疗费用并进行适当治疗。我们报告一例51岁男性病例,该患者无既往病史,出现全身无力、劳力性呼吸困难和运动耐量下降数月,检查发现患有严重的微血管病性贫血,检查结果提示TTP。病情稳定后,发现他继发于新诊断的恶性贫血的严重维生素B12缺乏,并接受皮下注射维生素B12治疗,临床症状和实验室指标有所改善。本病例突出了对维生素缺乏作为假性微血管病来源进行及时诊断和高度临床怀疑的必要性。